icon-    folder.gif   Conference Reports for NATAP  
  22nd Conference on Retroviruses and
Opportunistic Infections
Seattle Washington Feb 23 - 26, 2015
Back grey_arrow_rt.gif
Effectiveness of Sofosbuvir/Simeprevir for HIV/HCV Patients in Clinical Practice
  Reported by Jules Levin
CROI 2015 Feb 23-26, Seattle, WA
Jody Gilmore1, Kenneth Lynn1,5. Delisha Breen1, Stacey Trooskin2, Jihad Slim3, Nancy Scangarello3, Alvin Kingcade4, Katie Hunyh4, Vincent Lo Re III1,5, Jay R. Kostman1,5 1Viral Hepatitis Center, Penn Presbyterian Medical Center; 2Drexel University College of Medicine; 3St. Michael's Medical Center, Newark, NJ; 4Philadelphia Health Management Corporation; 5Center for AIDS Research, University of Pennsylvania
from Jules: PI resistance testing was conducted, apparently 36 patients had prior PI experience, 23 had no mutations, 10 had the Q80K, 4 the 155, 2 patients had other mutations.